HYPR (Hyperfine) ROCE %: -72.90% (As of Mar. 2026)


HYPR Hyperfine Inc HYPR
78 GF Score
Price $1.42
GF Value $1.31
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Hyperfine ROCE %?

Hyperfine HYPR -3.07% 78 ROCE % is -72.90% as of Mar. 2026. GuruFocus rates HYPR with a GF Score™ of 78/100 and a GF Value™ of $1.31 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hyperfine's annualized ROCE % for the quarter that ended in Mar. 2026 was -72.90%.

Hyperfine  (NAS:HYPR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hyperfine ROCE % Related Terms

Hyperfine ROCE % Historical Data

* Premium members only.

The historical data trend for Hyperfine's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyperfine ROCE % Chart

Hyperfine Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -51.05 -47.36 -45.68 -63.75 -79.16

Hyperfine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -78.84 -92.88 -104.04 -81.93 -72.90
HYPR
78GF Score
Hyperfine Inc HYPR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hyperfine ROCE % Calculation

Hyperfine's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-37.085/( ( (58.901 - 8.729) + (55.262 - 11.732) )/ 2 )
=-37.085/( (50.172+43.53)/ 2 )
=-37.085/46.851
=-79.16 %

Hyperfine's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-34.16/( ( (55.262 - 11.732) + (60.339 - 10.154) )/ 2 )
=-34.16/( ( 43.53 + 50.185 )/ 2 )
=-34.16/46.8575
=-72.90 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -72.90% mean?
Hyperfine (HYPR) has a ROCE % of -72.90% as of Mar. 2026.
Is Hyperfine's ROCE % too high?
Hyperfine's current ROCE % is -72.90%. Overall, Hyperfine has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hyperfine's ROCE % compare to OWLT and CVRX?
Hyperfine's ROCE % of -72.90% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hyperfine's current ROCE % is -72.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyperfine stock overvalued right now?
Based on GuruFocus' analysis, Hyperfine (HYPR) is currently considered Fairly Valued. The stock's GF Value™ is $1.31, compared to a current price of $1.42 — trading 8.4% above its estimated fair value. The current ROCE % is -72.90%. Hyperfine's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Hyperfine (HYPR), the current ROCE % is -72.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hyperfine (HYPR) Overvalued in 2026?

Based on GuruFocus' analysis, Hyperfine stock appears to be overvalued. The current stock price of $1.42 is trading 8.4% above its estimated GF Value™ of $1.31. GuruFocus considers Hyperfine to be Fairly Valued.

Key valuation signals for HYPR:

  • ROCE %: -72.90%
  • GF Value™: $1.31 vs. price of $1.42 (8.4% above fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the HYPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hyperfine Business Description

Address 351 New Whitfield Street, Guilford, CT, USA, 06437
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
78GF Score

Get the complete analysis for HYPR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.42
Price
$1.31
GF Value